Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Upgraded by StockNews.com
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) was upgraded by investment analysts at StockNews.com to a “sell” rating in a research note issued on Thursday. Other analysts also recently issued reports about the stock. JPMorgan Chase & Co. lifted their price target on shares of Syndax Pharmaceuticals from $39.00 to $41.00 and gave the company […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) was upgraded by investment analysts at StockNews.com to a “sell” rating in a research note issued on Thursday. Other analysts also recently issued reports about the stock. JPMorgan Chase & Co. lifted their price target on shares of Syndax Pharmaceuticals from $39.00 to $41.00 and gave the company […]
